HAErmony-1 (331-201) is the first in-human gene transfer study in Type I/ II HAE patients investigating an AAV5 mediated gene therapy that contains the human SERPING1 gene (BMN 331) for the prevention of HAE attacks. This evidence concerns the gene SERPING1 and hereditary angioedema.